Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
|
journal
|
October 2006 |
Improved system for helper-dependent adenoviral vector production
|
journal
|
November 2003 |
Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to Liver
|
journal
|
August 2008 |
Identification of Adenovirus Serotype 5 Hexon Regions That Interact with Scavenger Receptors
|
journal
|
February 2012 |
Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo
|
journal
|
February 2015 |
Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
|
journal
|
October 2010 |
Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery
|
journal
|
December 2012 |
IgM in microbial infections: Taken for granted?
|
journal
|
August 2009 |
Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues
|
journal
|
March 1996 |
Human Full-Length Coagulation Factor X and a GLA Domain-Derived 40-mer Polypeptide Bind to Different Regions of the Adenovirus Serotype 5 Hexon Capsomer
|
journal
|
April 2014 |
Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype
|
journal
|
December 1998 |
Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer
|
journal
|
July 2011 |
Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction
|
journal
|
October 2016 |
Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
|
journal
|
February 2008 |
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
|
journal
|
February 1997 |
Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy
|
journal
|
October 2021 |
Coagulation Factor X-Binding Protein from Deinagkistrodon acutus Venom Is a Gla Domain-Binding Protein
|
journal
|
November 1998 |
Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo
|
journal
|
July 2019 |
Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b
|
journal
|
May 2019 |
Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus
|
journal
|
January 1993 |
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
|
journal
|
July 2009 |
Circulating Antibodies and Macrophages as Modulators of Adenovirus Pharmacology
|
journal
|
April 2013 |
Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
|
journal
|
December 2012 |
Molecular Evolution of Human Adenovirus (HAdV) Species C
|
journal
|
January 2019 |
Systemic cancer therapy with engineered adenovirus that evades innate immunity
|
journal
|
November 2020 |
A Cluster of Basic Amino Acids in the Factor X Serine Protease Mediates Surface Attachment of Adenovirus/FX Complexes
|
journal
|
October 2011 |
Adenovirus Serotype 5-Specific Neutralizing Antibodies Target Multiple Hexon Hypervariable Regions
|
journal
|
January 2012 |
Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant Adenovirus
|
journal
|
January 2002 |
Polyreactivity of antibody molecules
|
journal
|
April 2004 |
Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum
|
journal
|
February 2018 |
Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor
|
journal
|
March 2018 |
Adenovirus hexon modifications influence in vitro properties of pseudotyped human adenovirus type 5 vectors
|
journal
|
January 2016 |
Adenovirus Serotype 5 Fiber Shaft InfluencesIn VivoGene Transfer in Mice
|
journal
|
May 2003 |
HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
|
journal
|
April 1997 |
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
|
journal
|
October 2010 |
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
|
journal
|
April 1993 |
Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies
|
journal
|
December 1999 |
Coagulation Factor Binding Orientation and Dimerization May Influence Infectivity of Adenovirus-Coagulation Factor Complexes
|
journal
|
September 2013 |
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
|
journal
|
May 2018 |
Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo
|
journal
|
March 2022 |
Evidence of frequent recombination among human adenoviruses
|
journal
|
February 2008 |
Hexon Hypervariable Region-Modified Adenovirus Type 5 (Ad5) Vectors Display Reduced Hepatotoxicity but Induce T Lymphocyte Phenotypes Similar to Ad5 Vectors
|
journal
|
August 2014 |
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
|
journal
|
February 2009 |
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
|
journal
|
April 2006 |
Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus
|
journal
|
September 2012 |
Impact of Natural IgM Concentration on Gene Therapy with Adenovirus Type 5 Vectors
|
journal
|
March 2015 |
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5
|
journal
|
May 2017 |
Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
|
journal
|
December 2008 |
Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
|
journal
|
September 1999 |
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
|
journal
|
March 2013 |
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes
in vivo
|
journal
|
April 2008 |
Characterization of species C human adenovirus serotype 6 (Ad6)
|
journal
|
March 2011 |
Computational Analysis of Two Species C Human Adenoviruses Provides Evidence of a Novel Virus
|
journal
|
October 2011 |
Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents
|
journal
|
November 2009 |